Novel Coronavirus (COVID-19) Vaccine Development – Wave 4

Given the ongoing roll-out of the COVID-19 vaccine across the US, InCrowd conducted its fourth wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and further predictions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.


  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Infectious disease doctors (n=101)
    • Other Specialists (n=300)
  • Screening Criteria:
    • Physicians identifying as at least somewhat familiar with vaccines in development for COVID-19
  • Fielding Period:
    • Mar 1st – 3rd, 2021

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more
RSV Tracker: Wave 3

RSV Tracker: Wave 3

Due to the surge in US respiratory syncytial virus (RSV) cases amongchildren and adults as reported in the news, InCrowd was interested inlearning more from Emergency Room physicians to understand thefollowing: • Growth in RSV cases over time• Severity-level changes...

read more